0 104

Cited 0 times in

TIS21 inhibits interleukin 6 (IL-6) expression via suppression of STAT3 activation in normal fibroblast cell

Authors
Linh, Nguyen Quy; Lim, In Kyoung; Park, Tae Jun
Department
Department of Biochemistry & Molecular Biology
Abstract
Interleukin 6 (IL-6) acts as a pro-inflammatory cytokine. IL-6 has important roles in cancer process, especially in cell proliferation. There are several reports which show that JAK/STAT3 signaling pathway can regulate IL-6 expression. STAT3 could be activated by Chk2 during DNA damage and senescence. TIS21 (12-o-tetradecanoyl-phorbol-13-acetate (TPA)-inducible sequence 21), ortholog of human B-cell translocation gene 2 (BTG2) is a tumor suppressor gene and down-regulated in various cancers. We hypothesized that TIS21 can down-regulate IL-6 expression via inhibition of STAT3 pathway. In this study, we show that IL-6 expression increases more than 2 fold in response to Chk2 overexpression in human diploid fibroblast (HDF) cell. At the mechanistic level, Chk2 up-regulates IL-6 expression at mRNA level by activating STAT3 pathway. We also observed that TIS21 inhibited IL-6 expression and down-regulated the levels of p-STAT3 and p-Chk2. Taking together, our results suggest that TIS21 has a role in IL-6 expression at mRNA level via down-regulation of Chk2, inhibiting Chk2 – STAT3 signaling pathway. The data exhibits anti-carcinogenic potential of TIS21 via down-regulation of IL-6 in HDF cell. However, the detail mechanism of this interplay is underway.
Appears in Collections:
Others > Poster > Poster
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse